CINC — CINCOR PHARMA INC
CINC (CINCOR PHARMA INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 27 funds have reported positions historically, with the sum of their latest reported stakes valued at $34.14M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2022 | 1.06M | $13.09M | 0.00% | Reduce |
| UBS Group AG history | Q4 2022 | 375.81K | $4.62M | 0.00% | Add |
| Citadel Advisors history | Q4 2022 | 224.90K | $2.76M | 0.00% | Add |
| Northern Trust Corp history | Q4 2022 | 202.37K | $2.49M | 0.00% | Add |
| Charles Schwab Investment Management history | Q4 2022 | 155.53K | $1.91M | 0.00% | Add |
| Point72 Asset Management history | Q4 2022 | 116.80K | $1.44M | 0.01% | New |
| Two Sigma Investments history | Q4 2022 | 115.86K | $1.42M | 0.01% | New |
| Fidelity Management & Research (FMR) history | Q4 2022 | 81.74K | $1.00M | 0.00% | Reduce |
| Goldman Sachs Group history | Q4 2022 | 79.45K | $976.44K | 0.00% | Add |
| BNY Mellon history | Q4 2022 | 75.62K | $929.39K | 0.00% | Add |
| Manulife Financial history | Q4 2022 | 68.62K | $823.32K | 0.00% | Add |
| D. E. Shaw & Co history | Q4 2022 | 45.09K | $554.21K | 0.00% | Reduce |
| Morgan Stanley history | Q4 2022 | 27.20K | $334.34K | 0.00% | Reduce |
| Balyasny Asset Management history | Q4 2022 | 26.46K | $325.21K | 0.00% | New |
| Bank of America Corp history | Q4 2022 | 24.01K | $295.11K | 0.00% | Add |
| Davidson Kempner Capital Management history | Q1 2022 | 15.00K | $262.00K | 0.01% | New |
| Renaissance Technologies history | Q3 2022 | 7.00K | $230.00K | 0.00% | New |
| Invesco Ltd history | Q3 2022 | 6.91K | $227.00K | 0.00% | New |
| Marshall Wace history | Q4 2022 | 15.54K | $190.96K | 0.00% | New |
| Deutsche Bank AG history | Q4 2022 | 10.71K | $131.56K | 0.00% | Add |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 |
|---|---|---|---|---|
| Vanguard Group | 619.28K | 630.64K | 1.17M | 1.06M |
| UBS Group AG | 2.15K | 872 | 89.92K | 375.81K |
| Citadel Advisors | — | — | 44.40K | 224.90K |
| Northern Trust Corp | 99.60K | 113.94K | 166.56K | 202.37K |
| Charles Schwab Investment Management | 88.89K | 91.28K | 138.20K | 155.53K |
| Point72 Asset Management | — | — | — | 116.80K |
| Two Sigma Investments | — | — | — | 115.86K |
| Fidelity Management & Research (FMR) | 82.17K | 85.23K | 184.83K | 81.74K |
| Goldman Sachs Group | 13.56K | 10.74K | 68.82K | 79.45K |
| BNY Mellon | 32.21K | 34.80K | 72.86K | 75.62K |
| Manulife Financial | 30.50K | 45.62K | 45.78K | 68.62K |
| D. E. Shaw & Co | 34.96K | 17.53K | 177.78K | 45.09K |
| Morgan Stanley | 3.04K | 23.08K | 76.75K | 27.20K |
| Balyasny Asset Management | — | — | — | 26.46K |
| Bank of America Corp | 9.30K | 26.39K | 10.13K | 24.01K |
| Marshall Wace | — | — | — | 15.54K |
| Deutsche Bank AG | 6.79K | 5.67K | 8.40K | 10.71K |
| Legal & General Investment Management America | 1.10K | 4.33K | 6.11K | 6.92K |
| T. Rowe Price Associates | 718.88K | 679.62K | 1.28M | 1.42M |
| Citigroup Inc | 1.02K | 1.28K | 2.56K | 1.15K |